| |
| |
|
| Insider
Information: |
Luci David P |
| Relationship: |
President and CEO, Dir... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
3,140,861 |
|
|
Indirect Shares
|
57,545 |
|
|
| Direct
Value |
$50,432 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,198,406 |
|
|
| Total
Value |
$50,432 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bioenvision Inc |
BIVN |
EVP & General Counsel |
2007-07-10 |
0 |
2003-11-19 |
0 |
Premium* |
|
|
Abeona Therapeutics Inc |
ABEO |
Director |
2009-06-01 |
263,217 |
2008-12-15 |
0 |
Premium* |
|
|
Plx Pharma Inc |
PLXP |
President, CEO, Secret... |
2014-03-18 |
1,829,447 |
2014-03-18 |
7,462 |
Premium* |
|
|
Acurx Pharmaceuticals, Inc. |
ACXP |
President and CEO, Dir... |
2024-01-03 |
1,048,197 |
2024-01-03 |
50,083 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACXP |
Acurx Pharmaceuticals, In... |
President and CEO |
• • • |
2024-01-03 |
4 |
OE |
$3.55 |
$70,066 |
D/D |
19,737 |
1,048,197 |
0 |
- |
|
| ACXP |
Acurx Pharmaceuticals, In... |
President and CEO |
• • • |
2022-07-27 |
4 |
B |
$3.80 |
$75,001 |
D/D |
19,737 |
1,028,460 |
3.23 |
- |
|
| ACXP |
Acurx Pharmaceuticals, In... |
President and CEOOfficer |
• • • |
2021-06-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,003,523 |
|
- |
|
| ACXP |
Acurx Pharmaceuticals, In... |
President and CEOOfficer |
• • • |
2021-06-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
50,083 |
|
- |
|
| PLXP |
Plx Pharma Inc |
President, CEO, Secretary |
• • • |
2014-03-18 |
4 |
B |
$12.00 |
$24,996 |
D/D |
2,083 |
1,829,447 |
3.15 |
- |
|
| PLXP |
Plx Pharma Inc |
President, CEO, SecretaryOffic |
• • • |
2014-03-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,462 |
|
- |
|
| PLXP |
Plx Pharma Inc |
President, CEO, SecretaryOffic |
• • • |
2014-03-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,827,364 |
|
- |
|
| ABEO |
Abeona Therapeutics Inc |
Director |
– • – |
2009-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
263,217 |
0 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Director |
– • – |
2009-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,259 |
63,217 |
0 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Director |
– • – |
2009-03-09 |
4 |
A |
$1.15 |
$69,000 |
D/D |
60,000 |
60,958 |
0 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Director |
– • – |
2009-01-05 |
4 |
A |
$0.96 |
$754 |
D/D |
785 |
958 |
0 |
- |
|
| ABEO |
Abeona Therapeutics Inc |
Director |
– • – |
2008-12-15 |
4 |
A |
$2.75 |
$476 |
D/D |
173 |
173 |
0 |
- |
|
| BIVN |
Bioenvision Inc |
EVP & General Counsel |
• – – |
2007-07-10 |
4 |
D |
$5.60 |
$1,736,862 |
D/D |
(310,154) |
0 |
0 |
- |
|
| BIVN |
Bioenvision Inc |
CFO & Gen. Counsel |
• – – |
2006-11-27 |
4 |
A |
$4.94 |
$247,000 |
D/D |
50,000 |
310,154 |
0 |
- |
|
| BIVN |
Bioenvision Inc |
CFO & Gen. Counsel |
• – – |
2006-11-27 |
4 |
D |
$4.94 |
$93,366 |
D/D |
(18,900) |
310,154 |
0 |
- |
|
| BIVN |
Bioenvision Inc |
CFO & Gen. Counsel |
• – – |
2006-04-03 |
4 |
OE |
$0.74 |
$80,850 |
D/D |
110,000 |
279,054 |
0 |
- |
|
| BIVN |
Bioenvision Inc |
CFO & Gen. Counsel |
• – – |
2006-03-06 |
4 |
S |
$7.96 |
$1,074,668 |
D/D |
(135,000) |
169,054 |
|
- |
|
| BIVN |
Bioenvision Inc |
CFO & Gen. Counsel |
• – – |
2006-02-28 |
4 |
S |
$8.57 |
$557,161 |
D/D |
(65,000) |
304,054 |
|
- |
|
| BIVN |
Bioenvision Inc |
Officer |
– – – |
2006-02-28 |
144 |
NP |
$0.00 |
$1,582,000 |
/ |
200,000 |
0 |
|
- |
|
| BIVN |
Bioenvision Inc |
CFO, General Counsel |
• – – |
2005-04-22 |
5 |
OE |
$0.74 |
$80,850 |
D/D |
110,000 |
369,054 |
0 |
- |
|
| BIVN |
Bioenvision Inc |
CFO, General Counsel |
• – – |
2005-03-23 |
5 |
B |
$5.60 |
$28,000 |
D/D |
5,000 |
369,054 |
0 |
- |
|
| BIVN |
Bioenvision Inc |
CFO, General Counsel |
• – – |
2005-01-07 |
5 |
OE |
$0.74 |
$180,850 |
D/D |
246,054 |
369,054 |
0 |
- |
|
| BIVN |
Bioenvision Inc |
CFO, General Counsel |
• – – |
2005-01-03 |
5 |
S |
$8.81 |
$210,964 |
D/D |
(23,946) |
369,054 |
0 |
- |
|
| BIVN |
Bioenvision Inc |
CFO, General Counsel |
• – – |
2004-12-30 |
5 |
S |
$9.00 |
$90,000 |
D/D |
(10,000) |
369,054 |
0 |
- |
|
| BIVN |
Bioenvision Inc |
officer |
– – – |
2004-11-24 |
144 |
NP |
$0.00 |
$317,395 |
/ |
33,946 |
0 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
